Ozempic and similar drugs, including Wegovy and Rybelsus (made by Novo Nordisk) and Trulicity and Mounjaro (made by Eli Lilly), are GLP-1 drugs initially approved for Type 2 diabetes treatment
Your doctor may perform tests to make sure you do not have tuberculosis or other infections Hypersensitivity
This study lacked a placebo control, so results should be interpreted cautiously
References Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R
TB-500 (TB-4) component Two Phase 2 dermal ulcer trials referenced in the Goldstein review (PMID 22074294) reported acceleration of healing without serious adverse events at the studied subcutaneous doses
Both tirzepatide and orforglipron can cause gastrointestinal side effects (nausea, vomiting, diarrhea, constipation)